Reducing tau can prevent abnormal brain activity associated with Alzheimer's disease, autism, and epilepsy.
When dysfunctional, somatostatin interneurons drive brain activity and provoke seizures.
Scientists have identified three acidic cannabinoids in cannabis that reduces seizure activity in mouse models of Dravet syndrome.
Levetiracetam, an inexpensive drug commonly used in the treatment of epilepsy, improved memory, learning, and cognition for Alzheimer's patients who experience epilepsy activity in their brains.
Adults who experienced traumatic events, including abuse and household dysfunction, as children had an increased risk of developing neurological conditions later in life. Additionally, researchers found a significant link between childhood trauma and depression and anxiety in adulthood.
Novel AI technology allows researchers to understand which brain regions directly interact with each other, which helps guide the placement of electrodes for DBS to treat neurological diseases.
Researchers report self-perception does not diminish nor does an individual's personality change as a result of closed-loop brain stimulation brain implants for the treatment of epilepsy.
Researchers have identified a circuit within the brain that may be responsible for respiratory dysfunction and sudden death associated with Dravet syndrome.
The release of 2-AG, a natural endocannabinoid that is suggested to be the brain's equivalent to THC, dampens down seizure activity but increases post-seizure oxygen deprivation in the brain.
Researchers believe they have found a cause of memory loss in epilepsy patients by recording single neurons in the brain.
A new system translates EEG data into a 3D movie which shows activity in all recorded regions of the brain. The heat map shows where seizures start and spread throughout the patient's brain, in addition to evaluating the speed of activity during a seizure.
K.Vita, a new oral dietary substance based on the ketogenic diet, reduced seizures by up to 50% in children and adults with drug-resistant epilepsy.
